This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. . Many places will either permit patients access to dispensaries and/or permit medical cannabis possession within a reasonable amount. Seizures, including those characteristic of epilepsy.
The real stories around medical marijuana (MMJ) are those of the patients who have experienced life-changing benefits from cannabis therapy. The positive impact it’s having on the lives of patients across West Virginia is significant. MMJ can help patients achieve better sleep patterns and improved overall health.
1, 2017, following a 2016 ballot measure. I certainly hope that other states follow Nevada’s lead and provide reassurances to licensed veterinarians that they can administer CBD or talk about it with patients without fear of facing disciplinary proceedings,” he said. But do medical cannabinoids actually help animal patients?
British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.
Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.
Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. tetrahydrocannabinol (THC).
Under the plan, some 3,000 patients in France will be treated with medical cannabis and monitored closely. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs.
Cancer symptoms don’t stop when patients cross state lines. Children with epilepsy don’t quit having seizures because they’re on vacation. In 2017, Florida legislators acknowledged the wealth of peer-reviewed scientific literature supporting the use of medical cannabis through statewide legalization.
LifeCannMD was founded by Dr. Fernando Fandiño-Sende in Miami, and is dedicated to the evaluation, education, and treatment of patients who qualify for Medical Cannabis, since June 2017, Florida residents with certain qualifying conditions can obtain a Medical Marijuana recommendation for treatment.
Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Medical cannabis has been legal in Poland since 2017. Medical patients are also responsible for 100% of the cost of medication, making it cost-prohibitive to many.
It’s no wonder that doctors are looking for new ways to treat patients with chronic pain without resorting to these highly addictive substances. Cannabinoids can be used to treat pain and inflammation, as well as other conditions such as epilepsy and multiple sclerosis (MS). appeared first on United Patients Group.
Virginia legalized some forms of medical marijuana in a very limited way in 2017. This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. Read on for everything a medical marijuana patient needs to know about MMJ in Virginia. Is MMJ Legal In Virginia?
Qualifying medical patients can purchase and consume medicinal CBD oil that contains less than 0.9% In 2017 , the state made it legal once again to grow hemp in an effort to support the agriculture industry, which is the largest industry in the state. Medical: Illegal Recreational: illegal Reciprocity: N/A. THC and more than 15% CBD.
Physicians who want to prescribe Medicinal Cannabis are required to jump through countless regulatory hoops, as are patients seeking treatment. And though the benefits of Medicinal Cannabis are currently being utilised by only a small number of patients, the future’s certainly looking brighter for pain sufferers in Australia.
These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. The main goal of the reform is to ease bureaucratic hurdles for patients and to improve the quality and consistency of medical cannabis. Severe epilepsy in minors.
IPR 2017-00503). 9,066,920 – “Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy” (“the 920 Patent”). Epidiolex was approved to treat two rare forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome. GW Pharma Ltd., In this case, the subject patent was U.S.
In July, 2017, a joint ministerial decision between the Ministers of Health and Justice legalized medical marijuana in Greece, and changed the classification of cannabis from a Table A drug to a Table B drug. In 2017 , Deputy Minister for Agriculture Yiannis Tsironis called for the legalization of cannabis cultivation for personal use.
CBD first appeared on the natural channel’s top 40 list in 2017, ranking 12th, after sales growth of more than 300% from the previous year. million more on CBD products in 2021 compared to 2017 — a 413.4% Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Two thirds of patients reported improvement in the frequency of seizures (399/622, 64%). Pamplona F, da Silva L and Coan A. Pamplona F, da Silva L and Coan A.
The society launched a campaign with the hashtag #ApprovedButDenied protesting the difficulty so many patients have faced attempting to obtain medical cannabis. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? ApprovedButDenied.
Severe nausea; Seizures, including those characteristic of epilepsy. Many Arizona patients have found success in managing their pain with marijuana after previously using opioid-based painkillers – the prescription pills at the center of the national opioid epidemic. Randall Friese, Arizona State Legislator.
Patients under the age of 18 must also have a parent or guardian registered as a caregiver on their behalf. Patients may purchase a 90 day supply of their medication. Patients may purchase medical cannabis in oil-based preparations such as lozenges, capsules, and vape pens. Can a Qualifying Patient Grow Cannabis in Virginia?
The experiment consists of a two-year cycle where up to 3,000 patients will be treated with medical cannabis. The ANSM plans to implement a patient registry which will be updated by doctors and pharmacies after getting consent from patients. About the Experiment. Where Does Cannabis Legality Stand in France?
A 2017 article shined a light on how medical marijuana is a preferred method of relief for seniors. The details are based on a study conducted in Israel from 2015 through October 2017. Of the 1186 patients in the study, more than 60 percent had been prescribed cannabis to treat pain associated with cancer and other medical issues.
Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case. Severe epilepsy in minors.
Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.
To become a Texas medical marijuana patient, you can first talk with one of our doctors (100% online via secure video chat) to see if you qualify and we will help you through the application process. There are currently 3 dispensing organizations within the state of Texas – they are: Fluent was licensed on September 1, 2017.
To become a Texas medical marijuana patient, you can first talk with one of our doctors (100% online via secure video chat) to see if you qualify and we will help you through the application process. There are currently 3 dispensing organizations within the state of Texas – they are: Fluent was licensed on September 1, 2017.
The first supply of medical cannabis for pediatric patients with epilepsy at the Buenos Aires National Children’s Garrahan Hospital was finally delivered. The law was passed in 2017, but it wasn’t regulated until November of last year. In over 80 percent of cases, cannabis has been proven to improve patients’ quality of life.
Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. topiramate. rufinamide. zonisamide. eslicarbazepine.
Do patients report more side effects from cannabidiol (CBD)-rich extract therapy or from purified CBD therapy? Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis Front. Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology.
Though Georgia is one of the last states to officially legalize medical cannabis, the state has been gradually reforming its laws around low-THC cannabis oil for qualifying patients. In 2015, Georgia passed HB 1, also known as the Haleigh’s Hope Act, allowing medical cannabis oil for medical use.
For instance, THC has shown the potential to help in the treatment of conditions like PTSD, depression, eating disorders, and epilepsy. These include the potential to relieve symptoms like nausea and vomiting in cancer patients after undergoing chemotherapy treatment. It also offers pain relief in some patients.
In 2017, newspapers quoted Duterte’s spokesman that the former was open to approving bills legalising medical cannabis. So far, the DDB and Food and Drug Administration (FDA) has approved the use of CBD for patients afflicted with epilepsy, such as the oral solution Epidiolex for treatment of seizures associated with severe forms of epilepsy.
Marijuana is being researched as a treatment for autism in more severe cases where patients are more violent and symptoms are more intense. Parents of autism patients have expressed a general concern for these drugs and their effectiveness in dealing with autism. Epilepsy seizures are caused by reduced inhibition.
West Virginia’s medical marijuana program was established to provide patients with qualifying medical conditions access to medical cannabis as an alternative treatment option. The program was enacted into law in April 2017 with the passage of the West Virginia Medical Cannabis Act. Let’s get into the details of the process.
I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate. I am a legal Florida medical marijuana patient since January 2017, as well as a traveling medical cannabis writer, patient educator and vocal advocate.
says it is expanding its medical cannabis product offerings for patients and related education for health professionals in Australia. Previously, only cannabis extract products such as cannabidiol (CBD) were available to Australian patients. patient management and legislation. Via Hemp Gazette. adverse and therapeutic effects.
Mexico’s supreme court ordered the health ministry on Wednesday to issue regulation within six months on medical marijuana use, saying its failure to do so after legalization in 2017 had put rights at risk for patients, including children.
Since 2017, West Virginia joined the majority of states in legalizing medical cannabis. Prior to a medical cannabis certification, patients must obtain a written certification from their physician stating that they have one of the qualifying conditions and that they would benefit from cannabis use.
West Virginia has emerged as a trailblazer in the realm of medical marijuana, implementing a comprehensive program to provide patients with access to this therapeutic treatment option. It aims to provide regulated and secure avenues for patients to obtain medical marijuana while ensuring adherence to stringent state laws and regulations.
It’s an issue around the world: Governments continue to approve expensive, cannabis-based pharmaceutical products for medicinal use, while cultivation of the plant remains illegal for patients (and their families) to grow at home. Thankfully, Peru recently corrected this problem by passing a law in July that expands cannabis patients’ rights.
But sometimes one unintended consequence of adult-use legalization is that the market no longer caters to medical patients. So, you have this attempt to legitimize healthcare and to adopt standards, to do things in a more scientific way, and in a more credible way, for patients and for industry. It’s a non-trivial issue.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content